Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder

Clinical trial NCT05600114 · COMPLETED

Trial details

NCT number: NCT05600114
Sponsor: EmpowerPharm Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Social Anxiety Disorder

Start date: 2022-10-27
Primary completion: 2023-12-13
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.